Literature DB >> 16831872

MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells.

Valérie Plaisance1, Amar Abderrahmani, Véronique Perret-Menoud, Patrick Jacquemin, Frédéric Lemaigre, Romano Regazzi.   

Abstract

Insulin release from pancreatic beta-cells plays an essential role in blood glucose homeostasis. Several proteins controlling insulin exocytosis have been identified, but the factors determining the expression of the components of the secretory machinery of beta-cells remain largely unknown. MicroRNAs are newly discovered small non-coding RNAs acting as repressors of gene expression. We found that overexpression of mir-9 in insulin-secreting cells causes a reduction in exocytosis elicited by glucose or potassium. We show that mir-9 acts by diminishing the expression of the transcription factor Onecut-2 and, in turn, by increasing the level of Granuphilin/Slp4, a Rab GTPase effector associated with beta-cell secretory granules that exerts a negative control on insulin release. Indeed, electrophoretic mobility shift assays, chromatin immunoprecipitation, and transfection experiments demonstrated that Onecut-2 is able to bind to the granuphilin promoter and to repress its transcriptional activity. Moreover, we show that silencing of Onecut-2 by RNA interference increases Granuphilin expression and mimics the effect of mir-9 on stimulus-induced exocytosis. Our data provide evidence that in insulin-producing cells adequate levels of mir-9 are mandatory for maintaining appropriate Granuphilin levels and optimal secretory capacity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831872     DOI: 10.1074/jbc.M601225200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  133 in total

Review 1.  Post-transcriptional regulation in metabolic diseases.

Authors:  Wook Kim; Eun Kyung Lee
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  Minireview: microRNA function in pancreatic β cells.

Authors:  Sabire Ozcan
Journal:  Mol Endocrinol       Date:  2014-12

Review 3.  microRNAs: critical regulators in Th17 cells and players in diseases.

Authors:  Bin Wei; Gang Pei
Journal:  Cell Mol Immunol       Date:  2010-04-05       Impact factor: 11.530

4.  miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction.

Authors:  Ying Zheng; Zhen Wang; Yiting Tu; Hongwei Shen; Zhijie Dai; Jian Lin; Zhiguang Zhou
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

5.  Loss of miR-182 affects B-cell extrafollicular antibody response.

Authors:  Yan-Feng Li; Xijun Ou; Shengli Xu; Zi-Bing Jin; Naoharu Iwai; Kong-Peng Lam
Journal:  Immunology       Date:  2016-03-08       Impact factor: 7.397

6.  Suppression and epigenetic regulation of MiR-9 contributes to ethanol teratology: evidence from zebrafish and murine fetal neural stem cell models.

Authors:  Dana L Pappalardo-Carter; Sridevi Balaraman; Pratheesh Sathyan; Eric S Carter; Wei-Jung A Chen; Rajesh C Miranda
Journal:  Alcohol Clin Exp Res       Date:  2013-06-25       Impact factor: 3.455

7.  A simple array platform for microRNA analysis and its application in mouse tissues.

Authors:  Xiaoqing Tang; Jozsef Gal; Xun Zhuang; Wangxia Wang; Haining Zhu; Guiliang Tang
Journal:  RNA       Date:  2007-08-03       Impact factor: 4.942

Review 8.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

9.  MicroRNA-206 regulates surfactant secretion by targeting VAMP-2.

Authors:  Honghao Zhang; Yujie Guo; Amarjit Mishra; Deming Gou; Narendranath Reddy Chintagari; Lin Liu
Journal:  FEBS Lett       Date:  2014-12-04       Impact factor: 4.124

Review 10.  Type 2 diabetes: new genes, new understanding.

Authors:  Inga Prokopenko; Mark I McCarthy; Cecilia M Lindgren
Journal:  Trends Genet       Date:  2008-10-25       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.